MOBIX LABS, INC (MOBX) Form 424B3 — Nov 16, 2026
Mobix Labs filed Prospectus Supplement No. 4 to incorporate an 8-K disclosing a 1-for-7 reverse stock split effective after market close November 16, 2026, cutting shares outstanding from roughly 23.6 million to 3.4 million.
Key figures
- Net Loss
- $9.09 million (vs $16.80 million prior quarter, -46%)
- Q4 Revenue
- $1.81 million (vs $789,000 prior quarter, +129% sequential)
- Gross Margin
- 44.5% vs 12.9% prior quarter
- Gross Profit
- $804,000 (+688% sequential)
- Closing Price
- 0.51
- Q4 Revenue Yoy
- -4%
- Operating Loss
- $6.56 million (vs $7.35 million prior quarter)
- Accounts Payable
- $4.88 million (down ~46% YoY)
- Q4 Product Revenue
- $1.43 million (+171% sequential)
- Registered Shares
- 3744161
- Total Liabilities
- $29.63 million (down 21% YoY)
- Fiscal Year Net Loss
- $41.86 million
- Reverse Split Ratio
- 1-for-7
- Stockholders Equity
- $4.87 million (vs ~$336,000 deficit a year earlier)
- Shares Outstanding Pre Split
- 23646570
- Shares Outstanding Post Split
- 3378082
AI analysis
Red flags6 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.